A meta-analysis of five studies including 49,795 patients with plaque psoriasis or psoriatic arthritis also verified the efficacy of anti–TNF-α therapy in decreasing the incidence of cardiovascular events (Yang et al., 2016). Here, TNF is linked to psoriatic arthritis.